- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted nanomedicine modalities for prostate cancer treatment
Authors
Keywords
Prostate cancer, Castration-resistant prostate cancer, Targeted therapeutics, Nanoparticles, Drug-ligand conjugate, Androgen deprivation therapy, Chemotherapy, Phytochemicals, Oncogenic pathways, Anti-androgens
Journal
DRUG RESISTANCE UPDATES
Volume 56, Issue -, Pages 100762
Publisher
Elsevier BV
Online
2021-03-20
DOI
10.1016/j.drup.2021.100762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatostatin Analogs in Clinical Practice: a Review
- (2020) Mariana Gomes-Porras et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Annual report to the nation on the status of cancer, part I: National cancer statistics
- (2020) S. Jane Henley et al. CANCER
- Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
- (2020) Wenxiao Jiang et al. DRUG RESISTANCE UPDATES
- Nanomedicine to target multidrug resistant tumors
- (2020) Elise Lepeltier et al. DRUG RESISTANCE UPDATES
- Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
- (2020) Luyao Long et al. DRUG RESISTANCE UPDATES
- PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
- (2020) Wallace Jones et al. Cancers
- Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
- (2020) Nir Shahar et al. DRUG RESISTANCE UPDATES
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
- (2020) Hang Zhang et al. MEDICINAL RESEARCH REVIEWS
- Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design
- (2019) Sara G. T. Pereira et al. MOLECULAR PHARMACEUTICS
- Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: In vitro and in vivo activity
- (2019) Anmar M. Nassir et al. LIFE SCIENCES
- A hybrid nanomaterial with NIR-induced heat and associated hydroxyl radical generation for synergistic tumor therapy
- (2019) Cheng Zhang et al. BIOMATERIALS
- Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems
- (2019) Asghar Narmani et al. DRUG DEVELOPMENT RESEARCH
- Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
- (2019) May Levin et al. Cell Death & Disease
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Intracellular Delivery of Glucose Oxidase for Enhanced Cytotoxicity toward PSMA‐Expressing Prostate Cancer Cells
- (2019) Nicholas Flynn et al. MACROMOLECULAR BIOSCIENCE
- Novel fibronectin-targeted nanodisk drug delivery system displayed superior efficacy against prostate cancer compared with nanospheres
- (2019) Luyao Wang et al. Nano Research
- PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells
- (2019) Maryam Afsharzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Multifaceted NIR-responsive polymer-peptide-enveloped drug-loaded copper sulfide nanoplatform for chemo-phototherapy against highly tumorigenic prostate cancer
- (2019) Kishwor Poudel et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies
- (2019) Amir Iravani et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes
- (2019) Halley M. Oyer et al. Frontiers in Pharmacology
- Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms
- (2019) Ali Fatehi Hassanabad Translational Lung Cancer Research
- Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment
- (2019) Ding Qu et al. CARBOHYDRATE POLYMERS
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
- (2019) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Folate-conjugated nanovehicles: Strategies for cancer therapy
- (2019) Batoul Farran et al. Materials Science & Engineering C-Materials for Biological Applications
- Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
- (2019) Ke Li et al. Frontiers in Pharmacology
- Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
- (2018) Santosh Kumar Singh et al. CANCER LETTERS
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
- (2018) Pauraic Mc Carron et al. CURRENT MEDICINAL CHEMISTRY
- Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
- (2018) Wei Zhang et al. International Journal of Nanomedicine
- Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
- (2018) Nadda Muhamad et al. International Journal of Nanomedicine
- Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
- (2018) Lisa Belfiore et al. JOURNAL OF CONTROLLED RELEASE
- Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA–Paclitaxel Conjugate
- (2018) Qingzhi Lv et al. MOLECULAR PHARMACEUTICS
- Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA)
- (2018) Yogita Patil et al. Nanomedicine-Nanotechnology Biology and Medicine
- A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy
- (2018) Luyao Wang et al. Nanoscale
- Cancer cell-selective, clathrin-mediated endocytosis of aptamerdecorated nanoparticles
- (2018) Shira Engelberg et al. Oncotarget
- Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin
- (2018) Simona Dostalova et al. Scientific Reports
- Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
- (2018) Karen A. Autio et al. JAMA Oncology
- PSMA Antibody-Conjugated Pentablock Copolymer Nanomicellar Formulation for Targeted Delivery to Prostate Cancer
- (2018) Alex Oselu Owiti et al. AAPS PHARMSCITECH
- Current taxane formulations and emerging cabazitaxel delivery systems
- (2018) Boyang Sun et al. Nano Research
- TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer
- (2018) Channing Paller et al. PROSTATE
- Role of Androgen Receptor in Prostate Cancer: A Review
- (2018) Kazutoshi Fujita et al. World Journal of Mens Health
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells
- (2018) Prajakta Tambe et al. International Journal of Nanomedicine
- Development of PSMA-targeted and core-crosslinked glycol chitosan micelles for docetaxel delivery in prostate cancer therapy
- (2018) Xiang Feng et al. Materials Science & Engineering C-Materials for Biological Applications
- Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment
- (2017) Meong Cheol Shin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy
- (2017) Minjie Pan et al. MEDICINE
- Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer
- (2017) Dhruba J. Bharali et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer
- (2017) Xuefang Ding et al. RSC Advances
- PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
- (2017) Orielyz Flores et al. Theranostics
- Targeted killing of prostate cancer cells using antibody–drug conjugated carbon nanohorns
- (2017) María Isabel Lucío et al. Journal of Materials Chemistry B
- Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
- (2017) Vanna Sanna et al. Scientific Reports
- Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy
- (2016) Wen-Ying Huang et al. ACS Applied Materials & Interfaces
- Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells
- (2016) Simona Dostalova et al. ACS Applied Materials & Interfaces
- Targeting Nanocarriers with Anisamide: Fact or Artifact?
- (2016) Athanasia Dasargyri et al. ADVANCED MATERIALS
- Toward a Better Understanding of the Complexity of Cancer Drug Resistance
- (2016) Michael M. Gottesman et al. Annual Review of Pharmacology and Toxicology
- A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer
- (2016) Oren Levy et al. BIOMATERIALS
- Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells
- (2016) Yuanyuan Zhang et al. CANCER LETTERS
- Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide
- (2016) R. Bassiouni et al. CLINICAL CANCER RESEARCH
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
- (2016) D. D. Von Hoff et al. CLINICAL CANCER RESEARCH
- PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer
- (2016) Prashanth K.B. Nagesh et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy
- (2016) Zhongjian Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer
- (2016) Tao Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide
- (2016) Wei Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Discovery of PSMA-specific peptide ligands for targeted drug delivery
- (2016) Wei Jin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A phase 2 study of BIND-014 (PSMA-targeted docetaxel nanoparticle) administered to patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
- (2016) Karen A. Autio et al. JOURNAL OF CLINICAL ONCOLOGY
- The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer
- (2016) M. Mattie et al. MOLECULAR CANCER THERAPEUTICS
- Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells
- (2016) Christopher H Stuart et al. Nanomedicine
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
- (2016) Lili Zou et al. Theranostics
- Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
- (2016) Jayanth Suryanarayanan Shankaranarayanan et al. Scientific Reports
- Polymeric Nanomedicine for Tumor-Targeted Combination Therapy to Elicit Synergistic Genotoxicity against Prostate Cancer
- (2015) Qingqing Yang et al. ACS Applied Materials & Interfaces
- Tumor Radiosensitization by Monomethyl Auristatin E: Mechanism of Action and Targeted Delivery
- (2015) L. Buckel et al. CANCER RESEARCH
- Bauhinia purprea agglutinin-modified liposomes for human prostate cancer treatment
- (2015) Keisuke Ikemoto et al. CANCER SCIENCE
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
- (2015) Theodoros Karantanos et al. EUROPEAN UROLOGY
- Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes
- (2015) Stephen T. Guest et al. EXPERIMENTAL CELL RESEARCH
- Galbanic acid inhibits HIF-1α expression via EGFR/HIF-1α pathway in cancer cells
- (2015) Morteza Eskandani et al. FITOTERAPIA
- Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes
- (2015) Xiang Li et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting
- (2015) Jyoti Roy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Enhancing Accumulation and Penetration of HPMA Copolymer–Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer
- (2015) Zheng-Hong Peng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking
- (2015) Yajie Gao et al. Nanoscale
- Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer
- (2015) Namdev L. Dhas et al. POWDER TECHNOLOGY
- Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice
- (2015) Ruibao Chen et al. PROSTATE
- Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers
- (2015) JUN GUO et al. Experimental and Therapeutic Medicine
- Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery
- (2015) Yanan Luo et al. Biomaterials Science
- Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors
- (2015) Ignace Vergote et al. Therapeutic Advances in Medical Oncology
- Delivery and therapeutic potential of human granzyme B
- (2015) Florian C. Kurschus et al. IMMUNOLOGICAL REVIEWS
- Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer
- (2015) W. Nathaniel Brennen et al. Oncotarget
- Neuropilin-1-Targeted Gold Nanoparticles Enhance Therapeutic Efficacy of Platinum(IV) Drug for Prostate Cancer Treatment
- (2014) Anil Kumar et al. ACS Nano
- GnRH-Gemcitabine Conjugates for the Treatment of Androgen-Independent Prostate Cancer: Pharmacokinetic Enhancements Combined with Targeted Drug Delivery
- (2014) Theodoros Karampelas et al. BIOCONJUGATE CHEMISTRY
- Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer
- (2014) Murali M. Yallapu et al. BIOMATERIALS
- Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer
- (2014) S. V. Liu et al. CLINICAL CANCER RESEARCH
- The folate receptor as a rational therapeutic target for personalized cancer treatment
- (2014) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Prostate cancer relevant antigens and enzymes for targeted drug delivery
- (2014) Ashutosh Barve et al. JOURNAL OF CONTROLLED RELEASE
- Nanoporous Activated Carbon Derived from Rice Husk for High Performance Supercapacitor
- (2014) Huaxing Xu et al. Journal of Nanomaterials
- Apoferritin applications in nanomedicine
- (2014) Zbynek Heger et al. Nanomedicine
- LHRH-Conjugated Micelles for Targeted Delivery of Antiandrogen to Treat Advanced Prostate Cancer
- (2014) Di Wen et al. PHARMACEUTICAL RESEARCH
- PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells
- (2014) Jian Jin et al. PLoS One
- Development of a polymer theranostic for prostate cancer
- (2014) Amanda K. Pearce et al. Polymer Chemistry
- The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption
- (2014) M W Lee et al. Cell Death & Disease
- Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
- (2014) Mannan Nouri et al. Frontiers in Oncology
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
- (2013) Qi Yin et al. ADVANCED DRUG DELIVERY REVIEWS
- Near-Infrared Light-Mediated Nanoplatforms for Cancer Thermo-Chemotherapy and Optical Imaging
- (2013) Zhenjiang Zhang et al. ADVANCED MATERIALS
- pH-Sensitive nano-systems for drug delivery in cancer therapy
- (2013) Juan Liu et al. BIOTECHNOLOGY ADVANCES
- Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
- (2013) Patrizia Limonta et al. CANCER TREATMENT REVIEWS
- Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment
- (2013) W Nathaniel Brennen et al. ENDOCRINE-RELATED CANCER
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging
- (2013) Naoya Harada et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protective role of oleuropein and its metabolite hydroxytyrosol on cancer
- (2013) M.P. Carrera-González et al. TRENDS IN FOOD SCIENCE & TECHNOLOGY
- Polymer–drug conjugates: Origins, progress to date and future directions
- (2012) Jindřich Kopeček ADVANCED DRUG DELIVERY REVIEWS
- Bufalin, a Traditional Oriental Medicine, Induces Apoptosis in Human Cancer Cells
- (2012) Noriyuki Takai et al. Asian Pacific Journal of Cancer Prevention
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Polymeric Conjugates for Drug Delivery
- (2012) Nate Larson et al. CHEMISTRY OF MATERIALS
- Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: Physicochemical investigations
- (2012) Dipak D. Kumbhar et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
- (2012) Giorgia Urbinati et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- GnRH Receptors in Cancer: From Cell Biology to Novel Targeted Therapeutic Strategies
- (2012) Patrizia Limonta et al. ENDOCRINE REVIEWS
- AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors
- (2012) Joerg Engel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Plumbagin, a medicinal plant (lumbago zeylanica )-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model
- (2012) Bilal Bin Hafeez et al. Molecular Oncology
- Rational Development of a Cytotoxic Peptide To Trigger Cell Death
- (2012) Rebecca J. Boohaker et al. MOLECULAR PHARMACEUTICS
- Prodrug Strategy for PSMA-Targeted Delivery of TGX-221 to Prostate Cancer Cells
- (2012) Yunqi Zhao et al. MOLECULAR PHARMACEUTICS
- Polyphenols: Key Issues Involved in Chemoprevention of Prostate Cancer
- (2012) Sebastiano Cimino et al. Oxidative Medicine and Cellular Longevity
- Combination Therapy of Antiandrogen and XIAP Inhibitor for Treating Advanced Prostate Cancer
- (2012) Michael Danquah et al. PHARMACEUTICAL RESEARCH
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors
- (2012) J. CARLSSON et al. Oncology Letters
- Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells
- (2011) Robert E. Carraway et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Advances in the field of nanooncology
- (2011) KK Jain BMC Medicine
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity: Figure 1.
- (2011) Marianne D. Sadar CANCER RESEARCH
- Glycosylation, galectins and cellular signaling
- (2011) Cecile Boscher et al. CURRENT OPINION IN CELL BIOLOGY
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells
- (2011) Yong Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Neuropilin-1 expression in cancer and development
- (2011) Adrian M Jubb et al. JOURNAL OF PATHOLOGY
- Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance
- (2011) Vicky Goler-Baron et al. PLoS One
- Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)
- (2010) Sachin S. Chandran et al. CANCER BIOLOGY & THERAPY
- Prostate cancer and curcumin: Add spice to your life
- (2010) Bharat B. Aggarwal CANCER BIOLOGY & THERAPY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists
- (2010) S. V. Liu et al. CLINICAL CANCER RESEARCH
- Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens
- (2010) Bernard Malavaud et al. EUROPEAN JOURNAL OF CANCER
- Targeting of drugs and nanoparticles to tumors
- (2010) Erkki Ruoslahti et al. JOURNAL OF CELL BIOLOGY
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Arabinogalactan−Folic Acid−Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells
- (2009) Roy I. Pinhassi et al. BIOMACROMOLECULES
- Reduction-sensitive polymers and bioconjugates for biomedical applications
- (2009) Fenghua Meng et al. BIOMATERIALS
- Glucose oxidase — An overview
- (2009) Sandip B. Bankar et al. BIOTECHNOLOGY ADVANCES
- Biodegradable polymeric nanoparticles based drug delivery systems
- (2009) Avnesh Kumari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel
- (2009) Lysann Sauer et al. INTERNATIONAL JOURNAL OF CANCER
- Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer
- (2009) Maulik R Shah et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
- (2009) Yu Chen et al. LANCET ONCOLOGY
- Amino acid containing thapsigargin analogues deplete androgen receptor protein via synthesis inhibition and induce the death of prostate cancer cells
- (2009) D. J. Vander Griend et al. MOLECULAR CANCER THERAPEUTICS
- Biodistribution of HPMA Copolymer-Aminohexylgeldanamycin-RGDfK Conjugates for Prostate Cancer Drug Delivery
- (2009) Mark P. Borgman et al. MOLECULAR PHARMACEUTICS
- Targetable HPMA Copolymer–Aminohexylgeldanamycin Conjugates for Prostate Cancer Therapy
- (2009) Mark P. Borgman et al. PHARMACEUTICAL RESEARCH
- Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid
- (2009) Veronica Yao et al. PROSTATE
- Plumbagin, a Medicinal Plant–Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
- (2008) Moammir H. Aziz et al. CANCER RESEARCH
- Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis
- (2008) P Makhov et al. CELL DEATH AND DIFFERENTIATION
- The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells
- (2008) Marie-Estelle Losfeld et al. EXPERIMENTAL CELL RESEARCH
- Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer
- (2008) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models
- (2008) D. Pchejetski et al. MOLECULAR CANCER THERAPEUTICS
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
- Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers
- (2008) Q Zhu et al. ONCOGENE
- Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species
- (2008) Anna A. Powolny et al. PHARMACEUTICAL RESEARCH
- Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway
- (2008) Konstantin Golovine et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search